A new approach to classify risk in dengue infection using bioelectrical impedance analysis

Dengue Bulletin

Volumn 31, Issue , 2007, Pages 58-74

  Ibrahim, Fatimah ^a   Abas, Wan Abu Bakar Wan ^a   Taib, Mohd Nasir ^b   Guan, Chan Chong ^c   Sulaiman, Saadiah ^d  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b University of Teknologi MARA   (Malaysia)

^c Pantai Hospital   (Malaysia)

^d DEPARTMENT OF PHARMACOLOGY   (Malaysia)

Author keywords

Bioelectrical impedance; Classify; Dengue infections; Reactance; Risk

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIOLELECTRICAL IMPEDANCE ANALYSIS; BLOOD VESSEL PERMEABILITY; CLINICAL PROTOCOL; CONTROLLED STUDY; DENGUE; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEMATOCRIT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMBRANE CONDUCTANCE; PROCESS DESIGN; PROCESS DEVELOPMENT; PROCESS TECHNOLOGY; RISK ASSESSMENT; SCHOOL CHILD; SEROLOGY; THROMBOCYTE COUNT;

EID: 56249101356     PISSN: 1020895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Skae FM. Dengue fever in Penang. Br Med J. 1902; 2:1581-1582.
2. Gordon SCE. Dengue: An introduction. In: Rudnick A, Lim TW, Editors. Dengue fever studies in Malaysia Institute for Medical Research. Malaysia Bulletin. 1986; 23:1-5.
3. World Health Organization. Annual Report (1998) of the WHO Collaborating Centre for Arbovirus Reference and Research (dengue and dengue haemorrhagic fever) by Department of Medical Microbiology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur; 1998.
4. World Health Organization. Annual Report (1999/2000) of the WHO Collaborating Centre for Arbovirus Reference and Research (dengue and dengue haemorrhagic fever) by Department of Medical Microbiology, Faculty of Medicine, University Malaya, 50603 Kuala Lumpur; 2000.
5. World Health Organization. Annual Report (2001) of the WHO Collaborating Centre for Arbovirus Reference and Research (dengue and dengue haemorrhagic fever) by Department of Medical Microbiology, Faculty of Medicine, University Malaya, 50603 Kuala Lumpur; 2001.
6. Data released by the Health Ministry's Director of Disease Control, Hasan Abdul Rahman in New Straits Times Newspaper (2 May 2007).
7. Dengue and dengue haemorrhagic fever. Nation Pg.29, The Star Newspaper 2005 (15 January 2005).
8. Liedtke RJ. (1997). Principles of bioelectrical impedance analysis. Available from: URL:http://www.rohan.sdsu.edu/~ens314/bia.tm
9. Máttar JA. Application of total body bioimpedance to the critically ill patient. Brazilian Group for Bioimpedance Study. New Horiz. 1996 Nov; 4(4): 493-503.
10. Ott M, Fischer H, Polat H, Helm EB, Frenz M, Caspary WF, Lembcke B. Bioelectrical impedance analysis as a predictor of survival in patients with human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 May 1; 9(1): 20-5.
11. Baumgartner RN. Electrical impedance and total body electrical conductivity. In: Roche AF, Heymsfield SB, Lohman TG Editors. Human body composition. Champaign, IL: Human Kinetics; 1996. p. 79-107.
12. Chungue E, Boutin JP, Roux J. [Significance of IgM titration by an immunoenzyme technic for the serodiagnosis and epidemiological surveillance of dengue in French Polynesia]. Res Virol. 1989 May-Jun; 140(3): 229-40. French.
13. Lam SK, Devi S, Pang T. Detection of specific IgM in dengue infection. Southeast Asian J Trop Med Public Health 1987 Dec;18(4):532-8.
14. Lam SK, Devine PL. Evaluation of capture ELISA and rapid immunochromatographic test for the determination of IgM and IgG antibodies produced during dengue infection. Clin Diagn Virol 1998 May 1;10(1):75-81.
15. Lam SK. Application of rapid laboratory diagnosis in dengue control. Asia Pac J Mol Biol Biotechnol. 1995; 3: 351-355
16. PanBio. Dengue duo IgM and IgG rapid strip test. Catalogue No. DEN-25S, 2001.
17. Biodynamics Model 450 Bioimpedance Analyzer user's guide, "Basic Principles of Bioimpedance Testing", 1st ed. Copyright © Biodynamics Corporation; 2000. p. 1-22.
18. World Health Organization. Dengue haemorrhagic fever, diagnosis, treatment, prevention and control. 2nd edn., Geneva: WHO, 1997.
19. Chua MN, Molanida R, de Guzman M, Laberiza F. Prothrombin time and partial thromboplastin time as a predictor of bleeding in patients with dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health. 1993; 24 Suppl 1: 141-3.
20. Tai DYH, Chee YC, Chan KW. The natural history of dengue illness based on a study of hospitalized patients in Singapore. Singapore Med J. 1999; 40: 238-242.
21. Kuo CH, Tai DI, Chang-Chien CS, Lan CK, Chiou SS, Liaw YF. Liver biochemical tests and dengue fever. Am J Trop Med Hyg. 1992 Sep; 47(3): 265-70.
22. Ibrahim F, Mohd NT, Wan Abas WAB, Sulaiman S, Chan CG. A novel approach to classify risk in dengue haemorrhagic fever using bioelectrical impedance analysis. IEEE Transactions on Instrumentation and Measurement. 2005 Feb; 54(1):237-244.
23. Ibrahim F. Prognosis of dengue fever and dengue haemorrhagic fever using bioelectrical impedance. PhD thesis. Department of Biomedical Engineering, Faculty of Engineering, University of Malaya, July 2005.
24. Bandyopadhyay S, Lum LC, Kroeger A. Classifying dengue: a review of the difficulties in using the WHO case classification for dengue haemorrhagic fever. Trop Med Int Health. 2006 Aug;11(8):1238-55.
25. Nguyen TL, Nguyen TH, Tieu NT. The impact of dengue haemorrhagic fever on liver function. Res Virol. 1997 Jul-Aug; 148(4):273-7.
26. Berhman RE, Kliegman RM. Nelson essentials of paediatrics. 4th edn. Philadelphia: WB Saunders Company, 2002.
27. Ganong WF. Review of Medical Physiology. 21st edn. New York: McGraw Hill, 2003.
28. McPhee SJ, Lingappa VR, Ganong WF, Lange JD. Pathophysiology of disease: an introduction to clinical medicine. 2nd edn. Connecticut: Appleton & Lange Prentice Hall, 1997.